From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy. [PDF]
Buczek T, Butrym A.
europepmc +1 more source
Aberrant glycosylation in hematologic malignancies: mechanisms, immune evasion, and therapeutic targeting. [PDF]
Lu X +8 more
europepmc +1 more source
The Exosome Landscape in Acute Myeloid Leukemia: From Molecular Mechanisms to Translational Frontiers. [PDF]
Vargas-Castellanos E +2 more
europepmc +1 more source
Rosuvastatin enhances the efficacy of venetoclax-azacitidine in older acute myeloid leukemia patients via reducing T-cell exhaustion. [PDF]
Zhai Y +9 more
europepmc +1 more source
Elranatamab for Treatment of Multiple Myeloma With Central Nervous Involvement Refractory to Other Interventions. [PDF]
Julian K, Peterson B, Mohyuddin GR.
europepmc +1 more source
Efficacy and Safety of Immune Checkpoint Inhibitors in the Treatment of Hematologic Malignancies: An Umbrella Review of Systematic Reviews and Meta-Analyses. [PDF]
Yu Z +6 more
europepmc +1 more source
Roles of extracellular vesicles in the pathogenesis of chronic myeloid leukemia. [PDF]
Hrdinova T, Kupcova Skalnikova H.
europepmc +1 more source
In-situ polymerization-mediated glycan density measurement on extracellular vesicle surface for acute myeloid leukemia diagnosis. [PDF]
Wu X +8 more
europepmc +1 more source
A first-in-class bifunctional antibody targeting CD20 and CD37 remodels the immune microenvironment in relapsed or refractory B-cell malignancies. [PDF]
Wang L +14 more
europepmc +1 more source
Smoldering multiple myeloma in transition: redefining early myeloma in the modern era. [PDF]
Landgren O.
europepmc +1 more source

